209 related articles for article (PubMed ID: 20956544)
1. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells.
Grassian AR; Schafer ZT; Brugge JS
J Biol Chem; 2011 Jan; 286(1):79-90. PubMed ID: 20956544
[TBL] [Abstract][Full Text] [Related]
2. ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.
Khan IA; Yoo BH; Masson O; Baron S; Corkery D; Dellaire G; Attardi LD; Rosen KV
Oncogene; 2016 Nov; 35(44):5759-5769. PubMed ID: 27109096
[TBL] [Abstract][Full Text] [Related]
3. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment.
Rayavarapu RR; Heiden B; Pagani N; Shaw MM; Shuff S; Zhang S; Schafer ZT
J Biol Chem; 2015 Apr; 290(14):8722-33. PubMed ID: 25681438
[TBL] [Abstract][Full Text] [Related]
4. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation.
Grassian AR; Metallo CM; Coloff JL; Stephanopoulos G; Brugge JS
Genes Dev; 2011 Aug; 25(16):1716-33. PubMed ID: 21852536
[TBL] [Abstract][Full Text] [Related]
5. Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells.
Walsh AM; Lazzara MJ
J Cell Sci; 2013 Oct; 126(Pt 19):4339-48. PubMed ID: 23868981
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment.
Schafer ZT; Grassian AR; Song L; Jiang Z; Gerhart-Hines Z; Irie HY; Gao S; Puigserver P; Brugge JS
Nature; 2009 Sep; 461(7260):109-13. PubMed ID: 19693011
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.
Worthington J; Bertani M; Chan HL; Gerrits B; Timms JF
BMC Cancer; 2010 Sep; 10():490. PubMed ID: 20840765
[TBL] [Abstract][Full Text] [Related]
8. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
9. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Bourguignon LY; Gilad E; Peyrollier K
J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
[TBL] [Abstract][Full Text] [Related]
10. Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.
Frogne T; Benjaminsen RV; Sonne-Hansen K; Sorensen BS; Nexo E; Laenkholm AV; Rasmussen LM; Riese DJ; de Cremoux P; Stenvang J; Lykkesfeldt AE
Breast Cancer Res Treat; 2009 Mar; 114(2):263-75. PubMed ID: 18409071
[TBL] [Abstract][Full Text] [Related]
11. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.
Zhang EY; Cristofanilli M; Robertson F; Reuben JM; Mu Z; Beavis RC; Im H; Snyder M; Hofree M; Ideker T; Omenn GS; Fanayan S; Jeong SK; Paik YK; Zhang AF; Wu SL; Hancock WS
J Proteome Res; 2013 Jun; 12(6):2805-17. PubMed ID: 23647160
[TBL] [Abstract][Full Text] [Related]
12. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
Yoon SO; Shin S; Lipscomb EA
Cancer Res; 2006 Mar; 66(5):2732-9. PubMed ID: 16510594
[TBL] [Abstract][Full Text] [Related]
13. ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth.
Khan IA; Yoo BH; McPhee M; Masson O; Surette A; Dakin-Hache K; Younis T; Bethune G; Rosen KV
Breast Cancer Res; 2018 Dec; 20(1):151. PubMed ID: 30545388
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
15. Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.
Young CD; Zimmerman LJ; Hoshino D; Formisano L; Hanker AB; Gatza ML; Morrison MM; Moore PD; Whitwell CA; Dave B; Stricker T; Bhola NE; Silva GO; Patel P; Brantley-Sieders DM; Levin M; Horiates M; Palma NA; Wang K; Stephens PJ; Perou CM; Weaver AM; O'Shaughnessy JA; Chang JC; Park BH; Liebler DC; Cook RS; Arteaga CL
Mol Cell Proteomics; 2015 Jul; 14(7):1959-76. PubMed ID: 25953087
[TBL] [Abstract][Full Text] [Related]
16. Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38alpha mitogen-activated protein kinase via Sprouty2 downregulation.
Swat A; Dolado I; Rojas JM; Nebreda AR
Mol Cell Biol; 2009 Jun; 29(12):3332-43. PubMed ID: 19364817
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.
Miralem T; Avraham HK
Mol Cell Biol; 2003 Jan; 23(2):579-93. PubMed ID: 12509456
[TBL] [Abstract][Full Text] [Related]
18. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
Li X; Huang Y; Jiang J; Frank SJ
Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250
[TBL] [Abstract][Full Text] [Related]
19. c-erbB2-induced disruption of matrix adhesion and morphogenesis reveals a novel role for protein kinase B as a negative regulator of alpha(2)beta(1) integrin function.
Lindberg LE; Hedjazifar S; Baeckström D
Mol Biol Cell; 2002 Aug; 13(8):2894-908. PubMed ID: 12181354
[TBL] [Abstract][Full Text] [Related]
20. Functional Redundancy between β1 and β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer.
Bui T; Rennhack J; Mok S; Ling C; Perez M; Roccamo J; Andrechek ER; Moraes C; Muller WJ
Cell Rep; 2019 Oct; 29(3):589-602.e6. PubMed ID: 31618629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
